Matinas BioPharma announces closing of $8.0 million public offering
Matinas announced its public offering of 8,000 shares of Series B Convertible Preferred Stock, or the Series B Preferred, with a stated value of $1,000 per share and convertible into an aggregate of 16,000,000 shares of common stock at a conversion price of $0.50 per share, closed June 21, 2018. June 22, 2018